These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 32600243)
1. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney. Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243 [TBL] [Abstract][Full Text] [Related]
2. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431 [TBL] [Abstract][Full Text] [Related]
3. pH-sensitive chitosan-deoxycholic acid/alginate nanoparticles for oral insulin delivery. Zhang YW; Tu LL; Tang Z; Wang Q; Zheng GL; Yin LN Pharm Dev Technol; 2021 Nov; 26(9):943-952. PubMed ID: 34372745 [TBL] [Abstract][Full Text] [Related]
4. Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin. Chen S; Guo F; Deng T; Zhu S; Liu W; Zhong H; Yu H; Luo R; Deng Z AAPS PharmSciTech; 2017 May; 18(4):1277-1287. PubMed ID: 27480441 [TBL] [Abstract][Full Text] [Related]
5. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study. Barbari GR; Dorkoosh F; Amini M; Bahari Javan N; Sharifzadeh M; Atyabi F; Balalaie S; Rafiee Tehrani N; Rafiee Tehrani M Int J Nanomedicine; 2018; 13():5127-5138. PubMed ID: 30233176 [TBL] [Abstract][Full Text] [Related]
8. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809 [TBL] [Abstract][Full Text] [Related]
9. Effect of insulin-coated trimethyl chitosan nanoparticles on IGF-1, IGF-2, and apoptosis in the hippocampus of diabetic male rats. Kalantarian G; Ziamajidi N; Mahjub R; Goodarzi MT; Saidijam M; Soleimani Asl S; Abbasalipourkabir R Restor Neurol Neurosci; 2018; 36(4):571-581. PubMed ID: 29889083 [TBL] [Abstract][Full Text] [Related]
10. Design and in vitro/in vivo Evaluation of Polyelectrolyte Complex Nanoparticles Filled in Enteric-Coated Capsules for Oral Delivery of Insulin. Arpaç B; Devrim Gökberk B; Küçüktürkmen B; Özakca Gündüz I; Palabıyık İM; Bozkır A J Pharm Sci; 2023 Mar; 112(3):718-730. PubMed ID: 36150470 [TBL] [Abstract][Full Text] [Related]
11. Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats. Li X; Qi J; Xie Y; Zhang X; Hu S; Xu Y; Lu Y; Wu W Int J Nanomedicine; 2013; 8():23-32. PubMed ID: 23293517 [TBL] [Abstract][Full Text] [Related]
12. Development of an M cell targeted nanocomposite system for effective oral protein delivery: preparation, in vitro and in vivo characterization. Song JG; Lee SH; Han HK J Nanobiotechnology; 2021 Jan; 19(1):15. PubMed ID: 33422063 [TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015 [TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers. Abd El-Hameed AM; Yousef AI; Abd El-Twab SM; El-Shahawy AAG; Abdel-Moneim A Biochemistry (Mosc); 2021 Feb; 86(2):179-189. PubMed ID: 33832416 [TBL] [Abstract][Full Text] [Related]
15. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Liu L; Zhou C; Xia X; Liu Y Int J Nanomedicine; 2016; 11():761-9. PubMed ID: 26966360 [TBL] [Abstract][Full Text] [Related]
16. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Ma Z; Lim TM; Lim LY Int J Pharm; 2005 Apr; 293(1-2):271-80. PubMed ID: 15778065 [TBL] [Abstract][Full Text] [Related]
18. Trigonella stellata reduced the deleterious effects of diabetes mellitus through alleviation of oxidative stress, antioxidant- and drug-metabolizing enzymes activities. Sheweita SA; ElHady SA; Hammoda HM J Ethnopharmacol; 2020 Jun; 256():112821. PubMed ID: 32251758 [TBL] [Abstract][Full Text] [Related]
19. The effect of insulin-loaded trimethylchitosan nanoparticles on rats with diabetes type I. Jamshidi M; Ziamajidi N; Khodadadi I; Dehghan A; Kalantarian G; Abbasalipourkabir R Biomed Pharmacother; 2018 Jan; 97():729-735. PubMed ID: 29102916 [TBL] [Abstract][Full Text] [Related]